Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line Therapy

The management of multiple primary cancers, an event not so infrequent in oncology practice, is a critical issue due to the lack of literature. In this study, we reported the case of a patient with non-small cell metastatic lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) who received...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Brunetti, Oronzo, Badalamenti, Giuseppe, De Summa, Simona, Calabrese, Angela, Argentiero, Antonella, Fucci, Livia, Longo, Vito, Galetta, Domenico, Perrotti, Pia Maria Soccorsa, Pinto, Rosamaria, Petriella, Daniela, Danza, Katia, Tommasi, Stefania, Leonetti, Francesco, Silvestris, Nicola
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2019
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6627355/
https://ncbi.nlm.nih.gov/pubmed/31146476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11060749
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars